Your browser doesn't support javascript.
loading
Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome.
Kastrinos, Fay; Ingram, Myles A; Silver, Elisabeth R; Oh, Aaron; Laszkowska, Monika; Rustgi, Anil K; Hur, Chin.
  • Kastrinos F; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York. Electronic address: Fk18@columbia.edu.
  • Ingram MA; Division of General Medicine, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York.
  • Silver ER; Division of General Medicine, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York.
  • Oh A; Division of General Medicine, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York.
  • Laszkowska M; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York.
  • Rustgi AK; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York.
  • Hur C; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and Vagelos College of Physicians and Surgeons, New York, New York; Division of General Medicine, Columbia Un
Gastroenterology ; 161(2): 453-462.e15, 2021 08.
Article en En | MEDLINE | ID: mdl-33839100
ABSTRACT
BACKGROUND AND

AIMS:

Lynch syndrome is associated with pathogenic variants in 4 mismatch repair (MMR) genes that increase lifetime risk of colorectal cancer. Guidelines recommend intensive colorectal cancer surveillance with colonoscopy every 1-2 years starting at age 25 years for all carriers of Lynch syndrome-associated variants, regardless of gene product. We constructed a simulation model to analyze the effects of different ages of colonoscopy initiation and surveillance intervals for each MMR gene (MLH1, MSH2, MSH6, and PMS2) on colorectal cancer incidence and mortality, quality-adjusted life-years, and cost.

METHODS:

Using published literature, we developed a Markov simulation model of Lynch syndrome progression for patients with each MMR variant. The model simulated clinical trials of Lynch syndrome carriers, varying age of colonoscopy initiation (5-year increments from 25-40 years), and surveillance intervals (1-5 years). We assessed the optimal strategy for each gene, defined as the strategy with the highest quality-adjusted life-years and incremental cost-effectiveness ratio below a $100,000 willingness-to-pay threshold.

RESULTS:

Optimal surveillance for patients with pathogenic variants in the MLH1 and MSH2 genes was colonoscopy starting at age 25 years, with 1- to 2-year surveillance intervals. Initiating colonoscopy at age 35 and 40 years, with 3-year intervals, was cost-effective for patients with pathogenic variants in MSH6 or PMS2, respectively.

CONCLUSIONS:

We developed a simulation model to select optimal surveillance starting ages and intervals for patients with Lynch syndrome based on MMR variant. The model supports recommendations for intensive surveillance of patients with Lynch syndrome-associated variants in MLH1 or MSH2. However, for patients with Lynch syndrome-associated variants of MSH6 or PMS2, later initiation of surveillance at 35 and 40 years, respectively, and at 3-year intervals, can be considered.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Neoplasias Colorrectales Hereditarias sin Poliposis / Biomarcadores de Tumor / Técnicas de Apoyo para la Decisión / Colonoscopía / Reparación de la Incompatibilidad de ADN / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged80 Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Variación Genética / Neoplasias Colorrectales Hereditarias sin Poliposis / Biomarcadores de Tumor / Técnicas de Apoyo para la Decisión / Colonoscopía / Reparación de la Incompatibilidad de ADN / Detección Precoz del Cáncer Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged80 Idioma: En Año: 2021 Tipo del documento: Article